CN101942040A - 肝素钠中多硫酸软骨素的去除方法 - Google Patents
肝素钠中多硫酸软骨素的去除方法 Download PDFInfo
- Publication number
- CN101942040A CN101942040A CN 201010287137 CN201010287137A CN101942040A CN 101942040 A CN101942040 A CN 101942040A CN 201010287137 CN201010287137 CN 201010287137 CN 201010287137 A CN201010287137 A CN 201010287137A CN 101942040 A CN101942040 A CN 101942040A
- Authority
- CN
- China
- Prior art keywords
- sodium
- concentration
- heparin sodium
- chlor
- chondroitin sulfate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000669 heparin Polymers 0.000 title claims abstract description 27
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 title claims abstract description 25
- 229960001008 heparin sodium Drugs 0.000 title claims abstract description 25
- 238000000034 method Methods 0.000 title claims abstract description 15
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical class FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 title abstract description 6
- 229920001287 Chondroitin sulfate Polymers 0.000 title abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000011347 resin Substances 0.000 claims abstract description 11
- 229920005989 resin Polymers 0.000 claims abstract description 11
- 239000007788 liquid Substances 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229920002567 Chondroitin Polymers 0.000 claims description 22
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 claims description 22
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 claims description 15
- 238000001556 precipitation Methods 0.000 claims description 9
- 238000004062 sedimentation Methods 0.000 claims description 8
- 238000005406 washing Methods 0.000 claims description 6
- 238000010521 absorption reaction Methods 0.000 claims description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 6
- 239000002244 precipitate Substances 0.000 abstract 4
- 239000011780 sodium chloride Substances 0.000 abstract 3
- 239000003957 anion exchange resin Substances 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 230000001376 precipitating effect Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 238000005660 chlorination reaction Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229960004676 antithrombotic agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- -1 sulfuric acid ester Chemical class 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102871371A CN101942040B (zh) | 2010-09-16 | 2010-09-16 | 肝素钠中多硫酸软骨素的去除方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102871371A CN101942040B (zh) | 2010-09-16 | 2010-09-16 | 肝素钠中多硫酸软骨素的去除方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101942040A true CN101942040A (zh) | 2011-01-12 |
CN101942040B CN101942040B (zh) | 2012-06-06 |
Family
ID=43434263
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102871371A Active CN101942040B (zh) | 2010-09-16 | 2010-09-16 | 肝素钠中多硫酸软骨素的去除方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101942040B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102603925A (zh) * | 2012-03-21 | 2012-07-25 | 东营天东生化工业有限公司 | 一种由粗品肝素钠直接生产依诺肝素钠的方法 |
CN102775523A (zh) * | 2012-07-30 | 2012-11-14 | 南京新百药业有限公司 | 一种制备高纯度低分子肝素钠的工艺 |
CN103804522A (zh) * | 2013-11-24 | 2014-05-21 | 青岛九龙生物医药有限公司 | 一种提高肝素钠纯度的方法 |
CN104479049A (zh) * | 2014-12-24 | 2015-04-01 | 青岛九龙生物医药有限公司 | 一种肝素钠粗品中杂质分析预处理的方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050004358A1 (en) * | 2001-02-27 | 2005-01-06 | Pasqua Oreste | Highly sulfated derivatives of K5 polysaccharide and their preparation |
CN101575385A (zh) * | 2008-05-09 | 2009-11-11 | 青岛九龙生物医药有限公司 | 萃取法分离肝素钠中的多硫酸软骨素的方法 |
CN101824098A (zh) * | 2010-02-12 | 2010-09-08 | 淮安麦德森化学有限公司 | 快速沉淀分离肝素钠中多硫酸软骨素的方法 |
-
2010
- 2010-09-16 CN CN2010102871371A patent/CN101942040B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050004358A1 (en) * | 2001-02-27 | 2005-01-06 | Pasqua Oreste | Highly sulfated derivatives of K5 polysaccharide and their preparation |
CN101575385A (zh) * | 2008-05-09 | 2009-11-11 | 青岛九龙生物医药有限公司 | 萃取法分离肝素钠中的多硫酸软骨素的方法 |
CN101824098A (zh) * | 2010-02-12 | 2010-09-08 | 淮安麦德森化学有限公司 | 快速沉淀分离肝素钠中多硫酸软骨素的方法 |
Non-Patent Citations (1)
Title |
---|
《沈阳化工学院学报》 20020925 张万忠等 肝素钠精制工艺研究 191-194 1 第16卷, 第03期 2 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102603925A (zh) * | 2012-03-21 | 2012-07-25 | 东营天东生化工业有限公司 | 一种由粗品肝素钠直接生产依诺肝素钠的方法 |
CN102603925B (zh) * | 2012-03-21 | 2013-12-11 | 东营天东制药有限公司 | 一种由粗品肝素钠直接生产依诺肝素钠的方法 |
CN102775523A (zh) * | 2012-07-30 | 2012-11-14 | 南京新百药业有限公司 | 一种制备高纯度低分子肝素钠的工艺 |
CN102775523B (zh) * | 2012-07-30 | 2014-06-25 | 南京新百药业有限公司 | 一种制备高纯度低分子肝素钠的工艺 |
CN103804522A (zh) * | 2013-11-24 | 2014-05-21 | 青岛九龙生物医药有限公司 | 一种提高肝素钠纯度的方法 |
CN105440164A (zh) * | 2013-11-24 | 2016-03-30 | 青岛九龙生物医药有限公司 | 一种提高肝素钠纯度的方法 |
CN103804522B (zh) * | 2013-11-24 | 2016-09-28 | 青岛九龙生物医药有限公司 | 一种提高肝素钠纯度的方法 |
CN104479049A (zh) * | 2014-12-24 | 2015-04-01 | 青岛九龙生物医药有限公司 | 一种肝素钠粗品中杂质分析预处理的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101942040B (zh) | 2012-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101619082B (zh) | 一种壳寡糖单体的分离纯化方法 | |
ES2668273T3 (es) | Uso de derivados de heparina químicamente modificada en drepanocitosis | |
WO2017032277A1 (zh) | 一种牛肺依诺肝素钠及其制备方法与应用 | |
CN101942040B (zh) | 肝素钠中多硫酸软骨素的去除方法 | |
CN108047343B (zh) | 伊贝母总多糖的制备方法及其应用 | |
US9540454B2 (en) | High purity heparin and production method therefor | |
CN106349407A (zh) | 一种低分子量岩藻糖化硫酸软骨素及其制备方法和在制备抗特鲁索综合征的药物中的应用 | |
CN104017102B (zh) | 乙醇沉淀法从肝素副产物制备舒洛地特原料的方法 | |
JP2006291028A (ja) | 低分子ヘパリンまたはその塩、ならびにその製造方法 | |
CN110776578B (zh) | 低分子海参糖胺聚糖及其应用 | |
CN106692255A (zh) | 一种麦蓝菜多糖水解物及其医药用途 | |
CN102936291B (zh) | 一种硒化聚甘露糖醛酸制备方法及其应用 | |
ITCO960031A1 (it) | Fucani a basso peso molecolare aventi attivita' anticoagulante antitrombinica e antitrombotica | |
CN101862349B (zh) | 蜈蚣有效部位及其应用 | |
EP4360638A1 (en) | Application of sulfate gluco-galacto-oligosaccharide in preparation of anticoagulant and/or antithrombotic drug | |
CN100457897C (zh) | 一种血栓溶解酶的制备方法及其应用 | |
CN102603910B (zh) | 一种茯苓多糖硫酸酯的制备方法 | |
CN100572547C (zh) | 鮟鱇鱼皮中硫酸皮肤素的提取纯化方法 | |
CN102585034B (zh) | 果胶磺化的方法 | |
CN103788231B (zh) | 一种从兔耳软骨中制备高纯度硫酸软骨素a的方法 | |
CN106749732A (zh) | 新疆一枝蒿多糖提取方法 | |
CN106349397B (zh) | 解聚海参糖胺聚糖组合物及其制备方法与应用 | |
CN104587465A (zh) | 一种抗病毒的利巴韦林-抗体偶联物及其制备方法 | |
CN106798729B (zh) | 一种纳米脂质微泡的制备方法及应用 | |
CN102048683A (zh) | 一种香菇多糖注射液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: DONGYING TIANDONG BIOCHEMICAL INDUSTRY CO., LTD. |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Yang Xiaohong Inventor after: Zhang Zaizhong Inventor after: Guo Lin Inventor after: Li Rong Inventor after: Wang Chunmei Inventor after: Liu Wei Inventor after: Yu Hexin Inventor before: Liu Wei Inventor before: Yu Hexin |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIU WEI YU HEXIN TO: YANG XIAOHONG ZHANG ZAIZHONG GUO LIN LI RONG WANG CHUNMEI LIU WEI YU HEXIN |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20110926 Address after: 257000 Shandong District of Dongying city in Dongying Province North Road No. 726 in the building Applicant after: SHANDONG HI-TECH CHEMICAL GROUP Co.,Ltd. Co-applicant after: DONGYING TIANDONG BIOCHEMICAL INDUSTRY Co.,Ltd. Address before: 257000 Shandong District of Dongying city in Dongying Province North Road No. 726 in the building Applicant before: SHANDONG HI-TECH CHEMICAL GROUP Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: DONGYING TIANDONG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: DONGYING TIANDONG BIOCHEMICAL INDUSTRY CO., LTD. Effective date: 20120917 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20120917 Address after: 257000 Shandong District of Dongying city in Dongying Province North Road No. 726 in the building Patentee after: SHANDONG HI-TECH CHEMICAL GROUP Co.,Ltd. Patentee after: DONGYING TIANDONG PHARMACEUTICAL Co.,Ltd. Address before: 257000 Shandong District of Dongying city in Dongying Province North Road No. 726 in the building Patentee before: SHANDONG HI-TECH CHEMICAL GROUP Co.,Ltd. Patentee before: DONGYING TIANDONG BIOCHEMICAL INDUSTRY Co.,Ltd. |
|
CP03 | Change of name, title or address |
Address after: 257000 West of HaoChun Road, Dongying District, Dongying City, Shandong Province Patentee after: Shandong Haike Chemical Co.,Ltd. Patentee after: DONGYING TIANDONG PHARMACEUTICAL Co.,Ltd. Address before: 257000 Shandong District of Dongying city in Dongying Province North Road No. 726 in the building Patentee before: SHANDONG HI-TECH CHEMICAL GROUP Co.,Ltd. Patentee before: DONGYING TIANDONG PHARMACEUTICAL Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201028 Address after: 257000 No. two, 1236 South Road, Dongying District, Shandong, Dongying Patentee after: DONGYING TIANDONG PHARMACEUTICAL Co.,Ltd. Address before: 257000 West of HaoChun Road, Dongying District, Dongying City, Shandong Province Patentee before: Shandong Haike Chemical Co.,Ltd. Patentee before: DONGYING TIANDONG PHARMACEUTICAL Co.,Ltd. |